Literature DB >> 11857340

Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.

Frances C Hall1, Joshua D Rabinowitz, Robert Busch, Kevin C Visconti, Michael Belmares, Namrata S Patil, Andrew P Cope, Salil Patel, Harden M McConnell, Elizabeth D Mellins, Grete Sonderstrup.   

Abstract

Immunodominant T cell epitopes from the autoantigen human cartilage glycoprotein 39 have previously been mapped in the context of HLA-DR*0401 and *0402, using mice expressing HLA-DR4 transgenes. We measured the dissociation rates of these epitopes from soluble recombinant DR*0401 and DR*0402 to assess the relationship between peptide/HLA-DR4 kinetic stability and immunogenicity. Experiments were performed at endosomal pH (5.5) and at cell surface pH (7), in the absence and presence of soluble recombinant HLA-DM (sDM). All (4/4) immunodominant peptide/HLA-DR complexes exhibit dissociation half-times of 1h to several days. In contrast, most (3/4) non-immunodominant complexes dissociate with half-times <30 min under at least one of these conditions. Interestingly, a complex which is stable except in the presence of HLA-DM at pH 5.5 is immunogenic only following peptide immunization, while a complex which is stable at acidic but not at neutral pH, is non-immunogenic following either whole protein or peptide immunization. These data indicate that kinetic stability of peptide/MHC complexes in vivo is a key determinant of immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857340     DOI: 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

1.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

2.  An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Authors:  Paula R Menges; Scott A Jenks; Elizabeth K Bikoff; David R Friedmann; Zackery A G Knowlden; Andrea J Sant
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

3.  Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.

Authors:  Lars-Egil Fallang; Elin Bergseng; Kinya Hotta; Axel Berg-Larsen; Chu-Young Kim; Ludvig M Sollid
Journal:  Nat Immunol       Date:  2009-08-30       Impact factor: 25.606

4.  Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.

Authors:  Hiroko Miyadera; Jun Ohashi; Åke Lernmark; Toshio Kitamura; Katsushi Tokunaga
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

5.  Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense.

Authors:  Shu-Chen Hung; Tieying Hou; Wei Jiang; Nan Wang; Shuo-Wang Qiao; I-Ting Chow; Xiaodan Liu; Sjoerd H van der Burg; David M Koelle; William W Kwok; Ludvig M Sollid; Elizabeth D Mellins
Journal:  J Immunol       Date:  2019-03-29       Impact factor: 5.422

6.  Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.

Authors:  Michael Rasmussen; Emilio Fenoy; Mikkel Harndahl; Anne Bregnballe Kristensen; Ida Kallehauge Nielsen; Morten Nielsen; Søren Buus
Journal:  J Immunol       Date:  2016-07-08       Impact factor: 5.422

7.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

8.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

9.  Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

Authors:  Christina K Baumgartner; Andrea Ferrante; Mika Nagaoka; Jack Gorski; Laurent P Malherbe
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

10.  HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; Omar Dominguez-Amorocho; Lawrence J Stern
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.